8 FDA clearances
- January 2007 – HairMax LaserComb granted the first ever FDA clearance as a home-use medical laser device for treatment of hair loss in males with androgenetic alopecia (pattern baldness).
- November 2009 & April 2011 – HairMax received FDA clearances on new LaserComb models.
- May 2011 – HairMax LaserComb granted the first ever FDA clearance as a home-use medical laser device for treatment of hair loss in females with androgenetic alopecia (pattern baldness).
- August 2011 – HairMax LaserComb continues to demonstrate leadership in clinical research and FDA clearances.
- September 2011 – HairMax LaserComb expanded its clearances to multiple devices to treat female hair loss.
- December 2014 – The HairMax LaserBand granted FDA clearance for the treatment of androgenetic alopecia in both men and women.
- June 2018 – RegrowMD Laser 272 laser cap was granted FDA Clearance for the treatment of androgenetic alopecia in both men and women. The device design utilises the unique BioLight Comfort feature which incorporates 272 laser diodes within a flexible, lightweight inner liner to optimally provide a direct flow of light energy to reach the scalp for optimal results.
